We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Bilibili (BILI - Free Report) : This company which provides online videos, live broadcasting and mobile games in China, has seen the Zacks Consensus Estimate for its current year earnings increasing 21.4% over the last 60 days.
Agnico Eagle Mines (AEM - Free Report) : This company which is a gold producer with mining operations in Canada, Mexico and Finland, and exploration activities in Canada, Europe, Latin America and the United States, has seen the Zacks Consensus Estimate for its current year earnings increasing 16.1% over the last 60 days.
Evercore (EVR - Free Report) : This company which is a premier global independent investment banking advisory firm, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
Veeva Systems (VEEV - Free Report) : This company which offers cloud-based software applications and data solutions for the life sciences industry, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.
BioCryst Pharmaceuticals (BCRX - Free Report) : This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has seen the Zacks Consensus Estimate for its next year earnings increasing 78.3% over the last 60 day.
BioCryst Pharmaceuticals, Inc. Price and Consensus
Image: Bigstock
New Strong Buy Stocks for June 25th
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:
Bilibili (BILI - Free Report) : This company which provides online videos, live broadcasting and mobile games in China, has seen the Zacks Consensus Estimate for its current year earnings increasing 21.4% over the last 60 days.
Bilibili Inc. Sponsored ADR Price and Consensus
Bilibili Inc. Sponsored ADR price-consensus-chart | Bilibili Inc. Sponsored ADR Quote
Agnico Eagle Mines (AEM - Free Report) : This company which is a gold producer with mining operations in Canada, Mexico and Finland, and exploration activities in Canada, Europe, Latin America and the United States, has seen the Zacks Consensus Estimate for its current year earnings increasing 16.1% over the last 60 days.
Agnico Eagle Mines Limited Price and Consensus
Agnico Eagle Mines Limited price-consensus-chart | Agnico Eagle Mines Limited Quote
Evercore (EVR - Free Report) : This company which is a premier global independent investment banking advisory firm, has seen the Zacks Consensus Estimate for its current year earnings increasing 11.6% over the last 60 days.
Evercore Inc Price and Consensus
Evercore Inc price-consensus-chart | Evercore Inc Quote
Veeva Systems (VEEV - Free Report) : This company which offers cloud-based software applications and data solutions for the life sciences industry, has seen the Zacks Consensus Estimate for its current year earnings increasing 3.6% over the last 60 days.
Veeva Systems Inc. Price and Consensus
Veeva Systems Inc. price-consensus-chart | Veeva Systems Inc. Quote
BioCryst Pharmaceuticals (BCRX - Free Report) : This company which is a leader in the use of crystallography and structure-based drug design for the development of novel therapeutics to treat cancer, cardiovascular diseases, autoimmune diseases, and viral infections, has seen the Zacks Consensus Estimate for its next year earnings increasing 78.3% over the last 60 day.
BioCryst Pharmaceuticals, Inc. Price and Consensus
BioCryst Pharmaceuticals, Inc. price-consensus-chart | BioCryst Pharmaceuticals, Inc. Quote
You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.